Overcoming Cross-Border Regulatory Challenges for IP Destruction in Clinical Trials
Overcoming Cross-Border Regulatory Challenges for IP Destruction in Clinical Trials How to Navigate Cross-Border Destruction Regulatory Challenges in Clinical Trials In global clinical trials, destruction of unused or returned Investigational Products (IPs) often involves cross-border movement from study sites to authorized disposal facilities. These movements introduce regulatory complexities due to varying import/export laws, hazardous waste…
Read More “Overcoming Cross-Border Regulatory Challenges for IP Destruction in Clinical Trials” »